Computational Drug Repositioning and Elucidation of Mechanism of Action of Compounds against SARS-CoV-2

The COVID-19 crisis called for rapid reaction from all the fields of biomedical research. Traditional drug development involves time consuming pipelines that conflict with the urgence of identifying effective therapies during a health and economic emergency. Drug repositioning, that is the discovery of new clinical applications for drugs already approved for different therapeutic contexts, could provide an effective shortcut to bring COVID-19 treatments to the bedside in a timely manner. Moreover, computational approaches can help accelerate the process even further. Here we present the application of computational drug repositioning tools based on transcriptomics data to identify drugs that are potentially able to counteract SARS-CoV-2 infection, and also to provide insights on their mode of action. We believe that mucolytics and HDAC inhibitors warrant further investigation. In addition, we found that the DNA Mismatch repair pathway is strongly modulated by drugs with experimental in vitro activity against SARS-CoV-2 infection. Both full results and methods are publicly available.

[1]  O. Kobiler,et al.  Histone Deacetylase Inhibitors Reduce the Number of Herpes Simplex Virus-1 Genomes Initiating Expression in Individual Cells , 2016, Front. Microbiol..

[2]  Xin Gao,et al.  Computer-aided drug repurposing for cancer therapy: approaches and opportunities to challenge anticancer targets. , 2019, Seminars in cancer biology.

[3]  Trey Ideker,et al.  A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing , 2020, bioRxiv.

[4]  Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs , 2020, Antimicrobial Agents and Chemotherapy.

[5]  R. Damoiseaux,et al.  Fluoxetine Is a Potent Inhibitor of Coxsackievirus Replication , 2012, Antimicrobial Agents and Chemotherapy.

[6]  J. Saiz,et al.  Antiviral Activity of Nordihydroguaiaretic Acid and Its Derivative Tetra-O-Methyl Nordihydroguaiaretic Acid against West Nile Virus and Zika Virus , 2017, Antimicrobial Agents and Chemotherapy.

[7]  Markus Depfenhart.  A SARS-CoV-2 Prophylactic and Treatment; A Counter Argument Against The Sole Use of Chloroquine , 2020, American Journal of Biomedical Science & Research.

[8]  R. Tagliaferri,et al.  Discovery of drug mode of action and drug repositioning from transcriptional responses , 2010, Proceedings of the National Academy of Sciences.

[9]  D. Bernardo,et al.  Computational Drug Networks: a computational approach to elucidate drug mode of action and to facilitate drug repositioning for neurodegenerative diseases , 2016 .

[10]  H. Rothan,et al.  Study the antiviral activity of some derivatives of tetracycline and non-steroid anti inflammatory drugs towards dengue virus. , 2013, Tropical biomedicine.

[11]  Diego di Bernardo,et al.  Mantra 2.0: an online collaborative resource for drug mode of action and repurposing by network analysis , 2014, Bioinform..

[12]  Diego di Bernardo,et al.  Comparing structural and transcriptional drug networks reveals signatures of drug activity and toxicity in transcriptional responses , 2017, npj Systems Biology and Applications.

[13]  B. Tirosh,et al.  Repression of viral gene expression and replication by the unfolded protein response effector XBP1u , 2019, bioRxiv.

[14]  D. Olivieri,et al.  Ambroxol: a multifaceted molecule with additional therapeutic potentials in respiratory disorders of childhood , 2011, Expert opinion on drug discovery.

[15]  C. Castilletti,et al.  Indomethacin Has a Potent Antiviral Activity against Sars Coronavirus , 2006, Antiviral therapy.

[16]  K. Dodou.  Investigations on gossypol: past and present developments , 2005, Expert opinion on investigational drugs.

[17]  M. Yano,et al.  Ambroxol suppresses influenza-virus proliferation in the mouse airway by increasing antiviral factor levels , 2002, European Respiratory Journal.

[18]  Diego di Bernardo,et al.  Drug-set enrichment analysis: a novel tool to investigate drug mode of action , 2015, Bioinform..

[19]  A Lavecchia,et al.  Virtual screening strategies in drug discovery: a critical review. , 2013, Current medicinal chemistry.

[20]  Lixia Chen,et al.  Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods , 2020, Acta Pharmaceutica Sinica B.

[21]  S. Sharif,et al.  Glutaminolysis and Glycolysis Are Essential for Optimal Replication of Marek’s Disease Virus , 2019, Journal of Virology.

[22]  Paul A Clemons,et al.  The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.

[23]  Evan Bolton,et al.  PubChem 2019 update: improved access to chemical data , 2018, Nucleic Acids Res..

[24]  G. Palù,et al.  Drug Repurposing Approach Identifies Inhibitors of the Prototypic Viral Transcription Factor IE2 that Block Human Cytomegalovirus Replication. , 2016, Cell chemical biology.

[25]  Zhicong Yang,et al.  Antiviral activity of Carbenoxolone disodium against dengue virus infection , 2016, Journal of medical virology.

[26]  G. Olinger,et al.  Antiviral Potential of ERK/MAPK and PI3K/AKT/mTOR Signaling Modulation for Middle East Respiratory Syndrome Coronavirus Infection as Identified by Temporal Kinome Analysis , 2014, Antimicrobial Agents and Chemotherapy.

[27]  Yoshimasa Tanaka,et al.  TMPRSS2: A potential target for treatment of influenza virus and coronavirus infections , 2017, Biochimie.

[28]  David Shum,et al.  Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs , 2020, Antimicrobial Agents and Chemotherapy.

[29]  Julio Saez-Rodriguez,et al.  Network based elucidation of drug response: from modulators to targets , 2013, BMC Systems Biology.

[30]  T. Pietschmann.  Clinically Approved Ion Channel Inhibitors Close Gates for Hepatitis C Virus and Open Doors for Drug Repurposing in Infectious Viral Diseases , 2016, Journal of Virology.

[31]  S. Baylin,et al.  Targeting Calcium Signaling Induces Epigenetic Reactivation of Tumor Suppressor Genes in Cancer. , 2016, Cancer Research.

[32]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[33]  D. Berlau,et al.  The Safety and Efficacy of Low‐Dose Naltrexone in the Management of Chronic Pain and Inflammation in Multiple Sclerosis, Fibromyalgia, Crohn's Disease, and Other Chronic Pain Disorders , 2018, Pharmacotherapy.

[34]  F. Cheng,et al.  Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2 , 2020, Cell Discovery.

[35]  Marc A Pfeffer,et al.  Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19 , 2020, The New England journal of medicine.

[36]  L. Liotta,et al.  Antiretroviral Drugs Alter the Content of Extracellular Vesicles from HIV-1-Infected Cells , 2018, Scientific Reports.

[37]  Diego di Bernardo,et al.  gene2drug: a Computational Tool for Pathway-based Rational Drug Repositioning , 2017, bioRxiv.

[38]  Ravi Iyengar,et al.  The Library of Integrated Network-Based Cellular Signatures NIH Program: System-Level Cataloging of Human Cells Response to Perturbations. , 2017, Cell systems.

[39]  R. Albrecht,et al.  SARS-CoV-2 launches a unique transcriptional signature from in vitro, ex vivo, and in vivo systems , 2020, bioRxiv.

[40]  Xin Gao,et al.  gep2pep: a bioconductor package for the creation and analysis of pathway-based expression profiles , 2019, Bioinform..

[41]  D. Liu,et al.  Coronavirus Infection Induces DNA Replication Stress Partly through Interaction of Its Nonstructural Protein 13 with the p125 Subunit of DNA Polymerase δ , 2011, The Journal of Biological Chemistry.